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Nonchlamydial, nongonococcal urethritis (NCNGU) is suggested to be a sexually transmitted disease in
men. NCNGU patients were compared to control subjects with regard to the presence of potentially infectious
bacteria in the first void urine. Patients’ pre- and post-antibiotic-treatment urine samples and two samples ob-
tained 2 weeks apart from healthy volunteers, who did not receive antibiotic therapy, were analyzed with broad-
spectrum PCR tests aiming at eubacterial small subunit rRNA genes. Restriction fragment length polymor-
phism analysis of the amplicons cloned from the mixtures of PCR products revealed that many different species
of microorganisms were found to be colonizing the male urethra. We document here clear differences in the
composition of the resident urethral flora between samples obtained from various individuals and between
samples obtained at various points in time for a single individual. No major changes in population complexity
were found upon antimicrobial treatment. In two of five patients a previously suggested pathogen (Mycoplasma
genitalium or Haemophilus parainfluenzae) was accurately identified on the basis of DNA sequencing. No ubiq-
uitous, azithromycin-sensitive organism was identified as a common pathogen in all patients, but up to 40% of
all clones represented as-yet-unclassified bacterial species. Relatively often Pseudomonas spp. or Pseudomonas-
like organisms were identified in the bacterial flora of patients. Interestingly, an as-yet-uncharacterized
microbial species was identified as a negative predictor of NCNGU. This species was identified in all control
subjects and was absent from all of the patient’ samples (5 of 5 versus 0 of 5, P  0.0079). This suggests that
NCNGU might also be diagnosed by assessing the absence rather than the presence of certain bacterial species.
Chlamydia trachomatis and Neisseria gonorrhoeae are com-
mon causes of urethritis in males (7, 14, 16). Nongonococcal
urethritis is diagnosed in over two million cases per year in the
United States. A significant fraction of the urethritis patients
(up to 50%), however, are not infected by either one of these
pathogens (7). In these cases, the clinical syndrome is referred
to as nonchlamydial nongonococcal urethritis (NCNGU).
NCNGU is a common condition, frequently diagnosed in sex-
ually transmitted disease (STD) clinics around the world. In
the pathogenesis of acute NCNGU, microorganisms other
than C. trachomatis or N. gonorrhoeae seem to play a role as
well, since a significant fraction of the patients involved re-
spond well to antibiotic treatment (1). Furthermore, data
showing that condoms are protective against NCNGU support
the hypothesis that NCNGU is an infectious disease (8, 25).
Despite extensive microbiological studies, no single causative
microbial species has been identified as the main cause of
NCNGU. Although Mycoplasma genitalium seems to be an
important candidate (4, 14, 17, 20, 28), with an incidence that
may be as high as 36% (4), many clinically overt cases still
remain microbiologically unexplained. Previous studies were
limited to selective searches for one or more traditional patho-
gens that are putatively involved in inflammation of the lower
genital tract in males. These pathogens included M. genitalium,
Ureaplasma urealyticum, or Trichomonas vaginalis, and searches
were performed by culture, PCR, or a combination of both
methods (14, 20, 28). Efforts to really identify novel pathogens
have employed culture methods mainly (10, 26). The downside
of this approach is that culture-dependent techniques may
not adequately elucidate the microbial diversity in the genito-
urinary tract. Molecular techniques have suggested that the
number of pathogenic microorganisms that have been cul-
tured to date probably equals only a fraction of the total (23).
Consequently, culture-based approaches have probably pro-
hibited the discovery of novel uropathogens, an omission that
underscores the need for additional molecular-microbiological
searches.
A potential solution to the inadequacy of microbiological
culture appears to be the use of diagnostic broad-range ribo-
somal DNA (rDNA) amplification in combination with phylo-
genetic studies (21). Eubacterial, domain-specific PCR primers
are particularly useful for the identification of putative human
pathogens. Amplified rDNA from bacteria can be sequenced,
and these sequences can be used in computerized database
searches to identify the bacterial species involved (31). This
approach turned out to be particularly successful in microbial-
etiological studies in chronic idiopathic prostatitis. Bacterial
rRNA genes could be detected in 77% of all patients, and
certain Vibrio species were identified as putative agents of
infection (19). In addition, the same strategy helped to identify
novel bacterial species, both in natural environments and clin-
ical syndromes (3, 11, 15, 22, 29).
The objective of the current research was to define the
* Corresponding author. Mailing address: Erasmus MC, Depart-
ment of Medical Microbiology and Infectious Diseases, Dr. Mole-
waterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: 31-10-
4635813. Fax: 31-10-4633875. E-mail: vanbelkum@bacl.azr.nl.
† Present address: University Hospital Groningen, Department of
Dermatology, 9713 GZ Groningen, The Netherlands.
1977
microbial communities present in the urethra of healthy male
volunteers and NCNGU patients. We searched for putative
pathogens and/or markers for a healthy microbial flora by
ribosomal PCR, which should allow for a detailed comparison
of the flora of control individuals and the spectrum of bacterial
species present in pre- and post-antibiotic-treatment samples
of NCNGU patients.
MATERIALS AND METHODS
Participants and procedures. Men attending the STD Outpatient Clinic of the
Department of Dermatology and Venereology of the Erasmus MC (University
Medical Centre Rotterdam, Rotterdam, The Netherlands) for a sexual health
assessment were eligible for the present study. Selected individuals provided
informed consent (Erasmus MC Medical Ethical Committee, protocol 00-859).
Major exclusion criteria were the use of antibiotics within the previous month
and a history of urethritis within the previous 3 months. Personal interviews
revealed that all five enrolled patients had clear symptoms of urethritis (penile
irritation in combination with discharge and/or dysuria [see Table 1]). Urethritis
was confirmed microscopically, on the basis of6 polymorphonuclear leukocytes
(PMNs) per l in the sediment of 12 ml of first-pass urine (FPU). The numbers
of PMNs were determined by using the standardized KOVA system (Hycor,
Garden Grove, Calif.) in full accordance with the manufacturer’s instructions.
Control subjects were five asymptomatic volunteers with no signs of urethritis
(6 PMNs/l). After the urethral meatus of each patient was washed with a
sterile gauze and tap water, 30 ml of FPU was collected into sterile tubes. In
addition, urethral swabs were obtained for confirmatory purposes. Infection by
N. gonorrhoeae was excluded microscopically (classical Gram stain) and by cul-
ture performed on a GC-LECT agar (Becton Dickinson, Alphen aan den Rijn,
The Netherlands). C. trachomatis infection was excluded by PCR analysis of FPU
by using the Cobas Amplicor Detection Reagent Kit and the Cobas Amplicor
machine (Roche Diagnostics, Mannheim, Germany) according to instructions of
the manufacturer. A total of 12 ml of FPU was used for the microscopic and
diagnostic evaluations described above, whereas 500 l was used for the Ampli-
cor tests. In preparation of the broad-spectrum ribosomal PCRs, 10 ml of FPU
was centrifuged for 10 min at 3,000 rpm. The sediment (ca. 75 to 300 l) was kept
at 80°C prior to processing. Patients with microscopically diagnosed urethritis
and a negative Gram stain for N. gonorrhoeae were treated with a single oral dose
of 1 g of azithromycin. Patients and control subjects were advised to abstain from
any form of sexual intercourse (vaginal, anal, and oral) and were asked to return
for reexamination after 2 weeks. At the second visit they delivered ca. 30 ml of
FPU, which was collected at home in the early morning, according to the
collection procedure described above. Again, 12 ml of FPU was microbiologically
evaluated for the presence of PMNs. A 10-ml portion was centrifuged, and the
sediment was kept at 80°C prior to PCR processing. The healthy volunteers
were not treated with azithromycin between the two samplings.
Tap water. To determine the possible microbiological contamination factor of
tap water used for washing the urethral meatus, 50 ml of first-run tap water was
collected in a sterile tube. This was centrifuged in 10-ml parts for 10 min at 3,000
rpm. The sediment was kept at 80°C prior to processing.
DNA purification. Part of the collected water and urine sediments (150 l) was
used for DNA extraction and purification. To the samples with a volume of150
l, a compensating amount of 50 mM Tris-HCl (pH 7.5)–0.1 mM EDTA–50 mM
glucose buffer was added to a total volume of 150 l. First, 75 l of lysostaphin
solution (10 mg/ml; Sigma, St Louis, Mo.) was added, and the mixture was heated
to 37°C for 30 min. Thereafter, 1 ml of guanidinium lysis buffer (4 mM guani-
dinium isothiocyanate, 0.1 M Tris-HCl [pH 6.4], 0.2 M EDTA, 0.1% Triton
X-100) was added, and the mixture was kept at room temperature for 1 h, after
which 50 l of Celite suspension was added. The samples were kept at room
temperature and mixed at regular intervals for 10 min (5). After a vortexing step
and centrifugation (15 s at 14,000 rpm in an Eppendorf centrifuge), the super-
natant was discarded and the pellet was washed twice with a second chaotropic
lysis buffer (4 M guanidinium isothiocyanate, 0.1 M Tris-HCl; pH 6.4), twice with
ethanol (70%) and, finally, once with acetone. The pellet was vacuum dried and
emulsified in 100 l of 10 mM Tris-HCl (pH 8.0). The sample was heated to 56°C
for 10 min and centrifuged (10 min at 14,000 rpm in an Eppendorf centrifuge).
The resulting supernatant was used as a template for PCR.
PCR tests. All PCRs were performed in GeneAmp 9600 or 9700 machines (PE
Applied Biosystems, Foster City, Calif.). The primers used for the 16S rDNA
PCR were EUB-L (5-CTTTACGCCCATTTAATCCG-3) and EUB-R (5-AG
A-GTTTGATCCTGGTTCAG-3). These generate an 500-bp fragment deriv-
ing from the 3-terminal end of the small-subunit (ssu) rRNA gene (30). A total
of 45 l of PCR mix was added to 5 l of the purified DNA solution. The PCR
mix consisted of 10 l of a 20 mM desoxynucleotide triphosphate stock solution
(Amersham Life Science, Cleveland, Ohio), 5 l of a 10-fold-concentrated Su-
perTaq PCR buffer (HT Biotechnology, Cambridge, United Kingdom), 0.5 l of
both primers, 28.92 l of distilled water, and 0.08 l of SuperTaq polymerase (15
U/l; HT Biotechnology, Cambridge, United Kingdom). The PCR consisted of
40 cycles of denaturation at 94°C (45 s), annealing at 55°C (45 s), and extension
at 72°C (45 s). A precycling denaturation step at 94°C was applied for 5 min. As
control sample, 50 l of PCR mix without additional DNA samples was run in
parallel. Then, 10-l portions of the PCR products were analyzed on a 1%
agarose gel containing ethidium bromide. Electrophoresis was performed in
0.5 TBE (50 mM Tris, 50 mM borate, 1 mM EDTA); gels were then stained in
aqueous ethidium bromide (10 ng/ml) and photographed under UV illumination.
Cloning of amplification products. The PCR amplification products (3 l of a
PCR mix) were used for ligation in pCR2.1 and transformed into competent
Escherichia coli TOP10 cells by using the Original TA Cloning Kit (Invitrogen,
San Diego Calif.). Clones were grown overnight at 37°C on 2YT agars (Yeast-
Trypton; Gibco-BRL, Breda, The Netherlands) containing ampicillin (100 g/
ml) and X-Gal (5-bromo-4-chloro-3-indolyl-	-D-galactopyranoside; 40 g/ml).
Possible transformants were identified by blue-white colony screening.
Screening for full-length inserts. DNA was liberated from possible recombi-
nants by suspending part of the colony in 100 l of distilled water. The suspen-
sion was boiled for 10 min and centrifuged for 10 min at 14,000 rpm in an
Eppendorf centrifuge. Next, 5 l of the supernatant was used as a template for
PCR. The primers used for amplification of the putative inserts in pCR2.1 were
M13 and T7 sequence specific (AACAGCTATGACCATG and TAATACGAC
TCACTATAGGG, respectively). then, 45 l of PCR mix, identical to the mix
used for the ssu rDNA PCR, was added. The PCR consisted of 30 cycles of
denaturation at 94°C (45 s), annealing at 56°C (45 s), and extension at 72°C (45
TABLE 1. Age, STD history, and clinical findings of patients and controls
Patient or
control no.
Age
(yr) STD history
a
First visit Second visit Sexual
orientationSymptoms PMNs/l Symptoms PMNs/l
Patient
1 37 NG Discharge, dysuria 21 None 5 Heterosexual
2 29 CT, PB Discharge, dysuria 31 None 5 Homosexual
3 25 CT, GW Dysuria 107 None 5 Heterosexual
4 32 NG, CT Dysuria 21 None 2 Heterosexual
5 44 NG, NCNGU Dysuria 61 None 1 Homosexual
Control
1 36 NCNGU None 1 None 1 Homosexual
2 30 PB None 0 None 3 Homosexual
3 50 None None 2 None 1 Heterosexual
4 29 None None 2 None 2 Heterosexual
5 40 None None 4 None 1 Heterosexual
a NG, N. gonorrhoeae; CT, C. trachomatis; PB, pubic pediculosis; GW, genital warts. All patients suffered from penile irritation.
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s). A precycling denaturation at 94°C was applied for 5 min. The PCR products
were visualized as described above. Only the samples with a full-length insert
(700 bp) were analyzed by restriction enzyme digestion. Per clinical sample, ca.
50 clones with full-length inserts were selected for further analysis.
RFLP analysis. We digested 15 l of the PCR product solution (M13/T7 PCR)
by using the restriction endonuclease AluI (New England Biolabs, Beverly,
Mass.). The restriction digests were analyzed in a 3% Metaphor agarose gel
containing ethidium bromide. The electrophoresis was performed in 0.5 TBE.
The gels were stained, examined, and photographed under UV illumination.
Analysis of the different restriction fragment length polymorphism (RFLP) pat-
terns was initially performed visually. If it was not possible to discriminate
between certain types, the software program GelCompar version 4.0 was also
used. When GelCompar was used, the position of DNA fragments shorter than
100 bp was ignored because these were not resolved well enough. For the
remaining DNA fragments, bands were analyzed according to Dice with the
tolerance set at 1.0% (optimization 
 0.50%, minimal area 
 0.1%). Two RFLP
patterns were regarded as the same if they matched for 100%. Different RFLP
types were given separate capital letter codes.
DNA sequencing. For bidirectional sequencing of the insert, the ssu rDNA
PCR (described above) was repeated. The nucleic acid sequence of the PCR
product was analyzed by Sanger’s method (BaseClear, Leiden, The Netherlands)
by using the Big Dye terminator sequencing kits 373, 377, and 3100 (PE Applied
Biosystems). The assembled ssu rDNA sequences were subjected to basic local
alignment search tool (BLAST) analysis (http://www.-ncbi.nlm.nih.gov/blast/;
version 1 June 2002). This analysis was used to determine which sequence in the
GenBank depository was most similar to the partial 3-terminal ssu rDNA se-
quence of the isolate. For the construction of phylogenetic trees, the sequence
data were compared by using multiple sequence alignment software as available
at www.genebee.msu (A. N. Belozersky Institute, Russian EMB Net Node) and
were expressed as phylograms (6).
RESULTS
Participants. The five patients had a mean age of 33 years;
the mean age of the controls was 37 years (Table 1). Although
patients were asked to return 2 weeks after the initial visit,
logistical difficulties caused the interval time to vary between
13 and 22 days. The control subjects all presented with an
interval time of precisely 14 days. All patients had a history of
some sort of urethritis (chlamydial, gonococcal, or NCNGU)
in the years prior to the study. In comparison, only one of the
control subjects suffered from NCNGU in the past. Patients
and control subjects refrained from sexual intercourse between
visits, had negative tests for N. gonorrhoeae and C. trachomatis,
and did not have signs of herpes genitalis or other overt sex-
ually transmissible diseases. Table 1 presents the urine PMN
cell counts, thereby illustrating that for all of the patients the
NCNGU episode cleared between the two visits, probably due
to the azithromycin therapy. Clinical complaints resolved dur-
ing the 2-week period as well. The cell counts for the controls
were always in the normal range (6).
RFLP analysis of ribosomal clones derived from tap water
sediments. Many bacterial ribosomal clones were obtained by
cloning the PCR products of the sediment of 50 ml of tap
water. Upon analysis of 55 clones, 15 clearly different RFLP
types were documented (see Table 2). Figure 1 shows the
distribution of these clones across the RFLP types, indicating
their relative frequencies of occurrence. There were seven
RFLP types (FA to FG) present that were never obtained from
controls and patients. Types B and D appeared to be most
common. Sequencing of some of the clones revealed that these
two types represented Pseudomonas spp., which are known to
be associated with water-rich environments. The amounts of
bacteria present in tap water probably mask the detection of
rDNA contaminants in the reagents used for PCR.
RFLP analysis of ribosomal clones derived from urine sed-
iments. Table 2 indicates the number of clones that were an-
alyzed for patients and volunteers by the RFLP approach. In
all, RFLP patterns were recorded for 472 clones derived from
patient samples, and 488 were documented for the healthy
controls. Ultimately, the RFLP database is comprised of 960
ribosomal fingerprints. AluI digestion of full-length inserts gen-
erally resulted in two to five conveniently resolved bands (Fig.
2). Different RFLP types represent the different types of ssu
rRNA genes that are present in microbes concentrated in the
urine sediment. It has to be emphasized, since we only em-
ployed a single restriction enzyme, that clones with identical
RFLP patterns do not necessarily represent identical bacterial
species. The distribution of clones (both in RFLP type and
FIG. 1. Distribution of ssu rDNA PCR RFLP types derived from
tap water. Indicated are the AluI types identified by uppercase letters
versus their frequency of occurrence among the 55 clones studied.
Note that types B and D, representing Pseudomonas spp., are by far the
most prevalent. The relative abundance represents the proportion the
number of representatives of a given RFLP type divided by the cumu-
lative number of all clones analyzed. The latter is set at 100%.
TABLE 2. Clones and RFLP types recovered from water,
control, and patient samples
Control no. sample type,
or patient no. Visit
No. of clones
analyzed
No. of
RFLP types
Controls
1 First 55 22
Second 50 15
2 First 46 19
Second 62 22
3 First 49 15
Second 50 22
4 First 49 14
Second 43 18
5 First 48 15
Second 36 11
Watera Singlea 55 15
Patients
1 First 44 10
Second 49 15
2 First 50 11
Second 49 14
3 First 46 28
Second 37 15
4 First 48 8
Second 49 11
5 First 50 18
Second 50 21
a The water sample was obtained only once.
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abundance) in control subjects and in patients is plotted in Fig.
3 and 4. Overall, 71 and 84 different RFLP types were obtained
in control subjects and patients, respectively. We found 62
different RFLP types present in patient samples that were
absent in control samples (CA-EJ). All clone libraries had a
relative dominance of a few types (e.g., the “watertypes” B and
D in most samples or CV and DE in the sample obtained
during the first visit of patient 2). It can be noted that some
types were only present during one visit (e.g., in control 4, types
Q and BF). Also, most of the types were not found in all of the
FIG. 2. PCR RFLP analysis of a randomly selected subset of the ssu rDNA clones obtained from the urine sediments of patient 1. Both on the
right and on the left, a molecular size marker is included (100-bp ladder; Bio-Rad, Veenendaal, The Netherlands); above the lanes, the uppercase
letter code for the RFLP patterns is indicated.
FIG. 3. Distribution of ssu rDNA PCR RFLP types derived from control individuals. Open bars indicate the clones identified from the urine
sediment obtained during the first visit; solid bars indicate clones from the sediment collected at the second visit. On the horizontal axis the RFLP
types are identified; on the vertical axis the relative abundance of the types is shown. For a definition of relative abundance, see the legend to Fig.
1. Codes indicated by an asterisk were hard to classify definitely and may represent heterogeneous types probably consisting of more than one
sequence motif.
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persons (e.g., type E was only present in control 1 and 3 and all
patients except number 2). Especially noteworthy is the fact
that RFLP type H was encountered in 9 of 10 samples derived
from control individuals. During NCNGU, this type was never
detected. This difference was highly significant from the statis-
tical viewpoint (9 of 10 versus 0 of 5; P 
 0.0020). Even when
calculated for the two groups of individuals, this significance
was maintained (5 of 5 versus 0 of 5; P 
 0.0079). For RFLP
type AQ, a similar trend was observed; in this case statistical
relevance was not reached.
On average, the fraction of variant clones identified at any
sampling moment was comparable. The index of variation, i.e.,
the ratio between the number of RFLP types and the overall
number of clones studied, was between 0.32 and 0.36. These
results indicate that the urethral flora shows extensive intra-
and interpersonal variation. It is interesting that in the volun-
teers, 47 of 138 cumulatively identified types disappeared dur-
ing the 2-week monitoring period. In the patients, who were
treated with antibiotics, 50 of 127 identified types seemed to
disappear. The difference in microbial dynamics between the
two groups is not statistically significant (two-sided Fisher ex-
act test, P 
 0.37). This implies that the azithromycin treat-
ment does not seem to drastically induce microbial species
extinction in the urethra: in both controls and patients, similar
elimination rates are encountered. On the other hand, species
also appear during the monitoring period. Again, no statisti-
cally relevant difference is noted between the groups (52 of 138
versus 51 of 127; P 
 0.71). In conclusion, azithromycin treat-
ment does not seem to severely affect the composition and
dynamics of the urethral flora. Interestingly, however, there
still is a relatively large group of ssu rRNA PCR RFLP types
that only occur in patients and not in controls (n 
 62). A
number of these disappear during the 2-week posttreatment
period (n 
 34). We assume that these represent antibiotic-
susceptible pathogenic bacteria and, therefore, these clones
will be addressed specifically below (see Fig. 5).
FIG. 4. Distribution of ssu rDNA PCR RFLP types derived from the five patients. Open bars indicate the clones identified from the urine
sediment obtained during the first visit; solid bars indicate clones from the sediment collected at the second visit. On the horizontal axis, the RFLP
types are identified; on the vertical axis, the relative abundance of the types is shown. For a definition of relative abundance, see the legend to Fig.
1. Codes indicated by an asterisk were hard to classify definitely and may represent heterogeneous types probably consisting of more than one
sequence motif.
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DNA sequencing. Due to the large number of different
RFLP types (140 in all), sequence analysis of all 16S rDNA
types was impractical. Some of the RFLP types found more
frequently (relative abundance of 10%) were sequenced to
assess the nature of the constant factors in the bacterial ure-
thral flora in more detail. Table 3 surveys the resemblance of
some of the more dominant clones with known bacterial spe-
cies based on BLAST searches in GenBank. All sequencing
analyses involved two independent clones per RFLP type. The
fact that in eight of nine cases identical or highly similar
sequences were obtained corroborates the reliability of the
RFLP analysis. It should be noted that clones with different
RFLP types (e.g., B and D, CV and DE, etc.) sometimes
revealed a close relatedness to the same bacterial genus. In
conclusion, Table 3 highlights that many water-borne bacterial
species, including Pseudomonas, Ralstonia, and Sphingomonas
spp., were identified as possible members of the healthy male
urethral flora, some of which are also identified as water con-
taminants. The latter observation raises the question of wheth-
er these species are tap water contaminants or genuine mem-
bers of the male urethral flora.
To determine which ssu rDNA types could possibly be as-
sociated with NCNGU, clones that appeared to be differen-
tially distributed among patients and controls were subjected
to sequencing. Type H, which, significantly, more often occurs
in the flora of healthy men, gave rise to ribosomal sequence
motifs that were most homologous to that of an uncultured
bacterial species encoded GKS2-124. GKS2-124 belongs to the
group of the -proteobacteria and was initially isolated from a
German freshwater lake (12). No obvious homology with
known pathogenic bacterial species was observed, the se-
quence showed a somewhat more distant homology to wa-
ter-thriving organisms such as Sphingomonas spp. A similar,
though not statistically significant, trend was also observed for
type AQ, occurring in four of five healthy controls and just one
patient.
FIG. 5. Overview of the 16S rDNA RFLP types that are present in the patients and absent from the controls. Open bars indicate the clones
identified from the urine sediment obtained during the first visit (t 
 0); solid bars indicate clones from the sediment collected at the second visit
(t 
 1). On the horizontal axis, the RFLP types are identified; on the vertical axis, the relative abundance of the types is shown. For a definition
of relative abundance, see legend to Fig. 1. Table 4 shows the sequence-based identification of a selection of these clones.
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Sequence analysis was also performed for one or two clones
with RFLP types that were present in the first samples pro-
vided by the patients but absent from the water sample, the
patient’s follow up samples, and both samples from the con-
trols (Fig. 5). Of the 32 different types of clones, 24 were
successfully sequenced (Table 4). Interestingly, patient 2 rep-
resents the only individual for whom a well-known putative
uropathogen was identified. Four of the different RFLP clones
were very similar to the rRNA sequence of M. genitalium,
thereby providing evidence for the fact that this person was
cured from an M. genitalium infection. This fact again illus-
trates that the experimental approach employed was solid and
that the outcome is relevant. However, the diversity observed
among the RFLP patterns is somewhat enigmatic since M. gen-
italium only harbors a single copy of the 16S rRNA gene. Wheth-
er this variation is due to mixed infections or PCR and cloning
induced errors is subject of current investigation. Patient 3
appeared to be infected by Haemophilus parainfluenzae (clone
DF/DL), a bacterial species that has been mentioned before,
but less convincingly as M. genitalium, in relation to NCNGU
(27). For the other patients, various previously identified bac-
terial species, but also some species that currently lack a de-
tailed description, matched entries in the GenBank database.
To strengthen the pathogen identification efforts, 18 minor
clones from the controls were also sequenced (Table 4). Inter-
estingly, 10 of 24 clones from the patients and 7 of 18 clones
derived from the healthy controls were matched to microbial
species that have never been cultured in vitro or have not yet
been precisely classified as a species. Since the homology
scores of the clone sequences with, for instance, the uncultured
bacterial clone DJAT-434, occurring in four of five patients
versus one of five control subjects, are variable, it is quite
possible that we detected here novel bacterial species (Table
4). Figure 6 illustrates the gross interrelatedness of the indi-
vidual bacterial species that were identified in Tables 3 and 4.
Besides two heterogeneous groups of various bacterial species
(Actinomyces, Veillonella, Corynebacterium, and Ralstonia spp.,
etc.), three major clusters can be discerned. Cluster A repre-
sents the streptococci, whereas cluster B derives from multiple
clones analyzed for the patient suffering from an M. genitalium
infection. Cluster C is the most interesting one since it is built
from four subclusters, one of which (C3) gathers the various
Haemophilus spp. The larger clusters C1 and C2 primarily
contain Pseudomonas spp. Interestingly, the DJAT-434 homo-
logues are clustered in the C2 group (except for the DJAT-434
homologue sequence derived from RFLP type DH from pa-
tient 4), a group consisting mainly of Pseudomonas-like organ-
isms. Apparently, the DJAT-434 homologues closely resemble
Pseudomonas spp. This leads to the conclusion that as-yet-
unidentified Pseudomonas species may play a significant role,
either as inducers of NCNGU or as opportunists occupying the
environmental niche created during the disease process.
DISCUSSION
With regard to the etiology of NCNGU in males, it is ap-
propriate to distinguish between acute and “chronic” disease.
Although no precise definition is available, NCNGU etiology is
probably multifactorial (2, 14). In order to gain more insight in
the pathogenesis of NCNGU in males, novel diagnostic ap-
proaches are mandatory (7). We focused here on acute cases of
urethritis, i.e., those not caused by N. gonorrhoeae or C. tra-
chomatis. To our knowledge, ours is the first study to approach
the long-standing enigma of the etiology of acute NCNGU in
men, employing broad-spectrum molecular-biological tech-
niques, such as ssu rDNA PCR and subsequent RFLP and
sequencing techniques. A downside of this approach is that
eukaryotic pathogens, such as T. vaginalis, are not detected.
These organisms are certainly important in a subset of
NCNGU cases (7, 18). Second, the data could be influenced by
the fact that some microorganisms are present in larger num-
bers or contain more ribosomal operons per genome than
others, thereby facilitating their detection. Consequently, the
TABLE 3. Sequencing results of RFLP clones dominating one or
more of the samples obtained from healthy control subjects
RFLP type Sequencing result Score
B Pseudomonas gessardii 1092
Pseudomonas libaniensis 1092
Pseudomonas synxantha 1092
B Pseudomonas libaniensis 1067
Pseudomonas gessardii 1067
Pseudomonas synxantha 1065
D Pseudomonas fluorescens ATCC 49642 852
Pseudomonas fluorescens ATCC 17574 852
Uncultured manure pit bacterium P320 852
Unidentified -proteobacterium OM93 852
Pseudomonas sp. clone NBO.1H 852
D Pseudomonas veronii 1074
Unidentified -proteobacterium 1061
E Streptococcus sp. oral strain H6 1043
Streptococcus sp. oral strain B5SC 1041
Streptococcus sp. oral clone BW009 1037
E Streptococcus mitis 1065
H Uncultured bacterium GKS2-124 979
Unidentified gamma proteobacterium 965
Sphingomonas echinoides 955
H Uncultured bacterium GKS2-124 981
Unidentified -proteobacterium 973
Sphingomonas echinoides 963
L Ralstonia pickettii 850
Ralstonia sp. strain APF11 850
Burkholderia pickettii ATCC 27511 835
L Ralstonia pickettii 850
Ralstonia sp. strain APF11 850
Burkholderia pickettii ATCC 27511 835
U Pseudomonas fluorescens bv. 771
Pseudomonas gessardii 771
Pseudomonas libaniensis 771
Uncultured bacterium GR-296.II.35 771
Pseudomonas sp. strain IC038 771
Unidentified bacteria 771
U Ralstonia sp. strain APF11 1086
Uncultured bacterium OSs75 1053
Pseudomonas pickettii 1045
AQ Sphingomonas echinoides 765
Sphingomonas echinoides 759
Uncultured bacterium GKS2-124 757
Unidentified -proteobacterium 757
AQ Unidentified -proteobacterium 997
Uncultured bacterium GKS2-124 989
Star-like microcolonies 977
Sphingomonas echinoides 971
BC Streptococcus mitis 1019
BC Streptococcus mitis 1080
BF Streptococcus agalactiae 807
Streptococcus agalactiae 805
BF Streptococcus agalactiae 1082
Streptococcus agalactiae 1074
Streptococcus agalactiae 1005
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spectrum of bacteria identified may not completely mimic the
urethral flora in situ. Third, definite proof for the association
of the bacteria identified with the urethral epithelium is not
available, i.e., the bacteria could also originate from the blad-
der or other anatomical locations.
Despite these pitfalls, we successfully documented the cure
of a M. genitalium infection in one of the subjects, which serves
as an excellent technological process control. Recent data by
Bjornelius et al. (4) revealed that M. genitalium could be de-
tected in more than 36% of all patients. It was also shown that
in 30% of all cases of chronic nongonococcal urethritis, U.
urealyticum could be detected (14), although the general liter-
ature is inconclusive with respect to the importance of this
bacterial species (14, 24, 27). We did not find evidence for
the presence of infectious U. urealyticum among our acute
NCNGU patients. In addition, various species of Haemophilus
have been implicated in NCNGU (27). Interestingly, patient 3
of the present study seemed to be harboring various species of
this particular genus as well. Haemophilus spp. were not en-
countered among the healthy controls. Finally, the presence of
various species of oral streptococci (Streptococcus gordoni, an
unidentified oral bacterium AP60-15, and Streptococcus saliva-
rius in patients 2, 3, and 5, respectively) may corroborate an
earlier suggestion concerning the involvement of oral sex in the
pathogenesis of NCNGU (13).
For some species, involvement in NCNGU was denounced
on the basis of previous studies performed by others (9, 32).
On the other hand, many other species have been previously
indicated as possibly involved in the establishment of NCNGU.
Whether these candidates, including, for instance, U. urealyti-
TABLE 4. Sequencing results of RFLP clones only present in patients’ t 
 0 samples or randomly selected from t 
 0 samples of controls
Patient or
control no. RFLP Sequencing result Score
Patient or
control no. RFLP Sequencing result Score
Patients
1 CT Uncultured Veillonella spp. 1096
DO Uncultured bacterium clone DJAT-434 797
Uncultured -proteobacterium 797
2 CQ Streptococcus gordonii 1068
CV Mycoplasma genitalium 1019
CW Mycoplasma genitalium 1080
CX Mycoplasma genitalium 1096
DB Uncultured bacterium clone DJAT-434 797
Uncultured -proteobacterium 797
DE Mycoplasma genitalium 1088
3 CJ Unidentified bacterium 6C 624
Methylobacterium spp. 595
CK Corynebacterium thomssenii 1007
DF Haemophilus parainfluenzae 969
Haemophilus paraphrophilus 946
DI Unidentified oral bacterium AP60-15 676
Gemella haemolysans 670
DL Haemophilus parainfluenzae 763
Pseudomonas spp. 728
DM Actinomyces turicensis 648
Bacterial spp. 634
DR Haemophilus paraphrophilus 959
Haemophilus parainfluenzae 959
DU Corynebacterium genitalium 946
Uncultured Corynebacterium sp. 473
DV Pseudomonas fluorescens 1051
4 DH Uncultured bacterium clone DJAT-434 735
Uncultured -proteobacterium 735
DY Pseudomonas fluorescens 1082
5 CB Uncultured bacterium clone TFBME10 613
Pseudomonas sp. G2 613
CH Variovorax sp. strain HAB-30 920
DB Uncultured bacterium clone DJAT-434 706
Pseudomonas sp. 706
DP Uncultured bacterium clone DJAT-434 706
Uncultured -proteobacterium 706
EB Uncultured bacterium D29A 1063
Streptococcus salivarius 1061
Controls
1 K Mesorhizobium loti 932
Rhizobium sp. strain CJ5 924
Rhizobium loti 924
M Pseudomonas marginalis 1072
Pseudomonas spp. 1072
Pseudomonas reactans 1072
Pseudomonas veronii 1072
H Unidentified bacterium ox-SCC-25/5 946
Unidentified bacterium ox-SCC-36/29 930
O Uncultured Comamonas spp. 876
Pseudomonas testosteroni 876
Comamonas testosteroni 876
P Peptostreptococcus genospecies 500
Peptostreptococcus spp. 456
T Uncultured Comamonas spp. 891
Pseudomonas testosteroni 891
Comamonas testosteroni 891
AJ Uncultured eubacterium WD293 1017
Pseudomonas mephitica 1005
AK Uncultured eubacterium WD293 1036
Agricultural soil bacterium 1027
AN Pseudomonas spp. 1052
Pseudomonas gessardii 1046
Pseudomonas libaniensis 1046
G Uncultured bacterium clone DJAT-434 783
Uncultured -proteobacterium 783
2 BG Sphingomonas spp. 787
Uncultured bacterium GKS2-124 785
AO Ralstonia detusculanense 628
Ralstonia spp. 628
Uncultured bacterium OSs7 628
3 V Unidentified bacterium rM7 648
Comamonas testosteroni 640
AE Ralstonia detusculanense 713
Ralstonia spp. 713
Burkholderia spp. 682
AF Pseudomonas jessenii 653
Pseudomonas spp. 653
Uncultured eubacterium 647
AG Pseudomonas sp. strain G2 1036
Pseudomonas sp. strain
NZ66/64/124/122/113/108/106/65
1028
Pseudomonas synxantha 1028
4 AM Streptococcus agalactiae 624
Streptococcus agalactiae 600
BQ Actinomyces viscosus 997
Actinomyces viscosus 908
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cum and Gardnerella vaginalis (9, 19), should be excluded from
future studies cannot be decided on the basis of the present
study, since the number of patients was kept low because of the
experimental complexity of our in vitro work. We did not
identify obvious and novel, putatively pathogenic bacterial spe-
cies that are 100% associated with acute NCNGU. Although
the RFLP analyses identified numerous types that were con-
fined to pretreatment patient samples, DNA sequencing re-
vealed that not a single bacterial species was exclusively pres-
ent in all five disease-related, pretreatment samples and absent
in all control samples. However, several uncharacterized bac-
terial species were identified more often (for instance, the
DJAT 434 clone was detected in four of five patients versus
one of five control subjects). In addition, Fig. 6 highlights the
fact that, among the patients, Pseudomonas-like bacterial spe-
cies were identified relatively frequently. The prevalence in
NCNGU and the pathogenic potential of these bacterial spe-
cies need to be defined more precisely. This requires the de-
velopment of diagnostic tests for these elusive microorganisms
that allow larger groups of patients to be screened. The reverse
situation was documented once: RFLP type H occurred in all
of the controls and in none of the patients. This difference,
even with the limited number of individuals included in the
current study, is statistically significant. The bacterial species
most homologous to the RFLP type H DNA sequence ap-
peared to have been detected in fresh lake water (12). Whether
this bacterial species acts as a putative probiotic or whether it
is simply outcompeted by the pathogens involved remains to be
elucidated, just as diagnostic tests for this species need to be
developed in order to more accurately determine its preva-
lence in healthy and diseased male urethras.
The major findings presented here are, first, the significant
inter- and intrapersonal variability of the urethral flora, both in
healthy and infected individuals, although this conclusion may
be biased by the fact that only 50 clones were analyzed per
urine sample. Second, azithromycin treatment seems to have
little effect on the variability, complexity, and dynamics of the
resident flora: many species not only disappear or appear dur-
ing antibiotic treatment but also in the healthy, untreated sit-
uation. It is reassuring to see that in two of five patients,
previously suggested pathogens were encountered that disap-
peared upon antibiotic treatment. The detection of a diversity
of uncharacterized Pseudomonas-like bacterial species suggests
that there is much more to explore in the bacterial flora of the
male urethra, whereas the detection of bacterial species that
disappear upon disease development may have important fu-
ture implications to the therapy of NCNGU.
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